The Digital Revolution of Drug Labelling: FHIR and the Global Blueprint for e-Labelling
The Digital Revolution of Drug Labelling: FHIR and the Global
HL7 developed a global blueprint using FHIR standards for digital drug labeling and e-labeling.
Summary
Today's healthcare sector is at a digital transformation crossroads, with significant shifts occurring in how drug information is handled. This movement centers on efforts to achieve global standardization through electronic labelling (e-Labelling) utilizing FHIR.
Key Players
Details
This article addresses the trend of digital transformation within the healthcare sector, focusing specifically on the challenges related to pharmaceutical information provision and handling. Under the theme 'The Digital Revolution of Drug Labelling: FHIR and the Global Blueprint for e-Labelling,' it discusses the necessity of electronic labelling (e-Labelling) using FHIR (Fast Healthcare Interoperability Resources) and its potential as a global standardization blueprint. The complexity of drug information, coupled with regional variations in data management, has been a major challenge. To overcome this, the industry aims to adopt international interoperability standards like FHIR, creating a mechanism where all stakeholders can exchange information based on a common data model. This is not merely about digitizing labels; it represents a comprehensive system transformation aimed at enhancing consistency and accessibility of information throughout the entire drug lifecycle. Its goals include improving patient safety and optimizing the efficiency of the entire supply chain. This movement highlights the forefront of international healthcare IT standardization.
Technology Note
FHIR(Fast Healthcare Interoperability Resources)は医療データ交換の国際標準。このエントリの関連技術: HL7
Original content copyright by respective publishers